Symbol="NAOV"
AssetType="Common Stock"
Name="NanoVibronix Inc"
Description="NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of non-invasive biological response activating devices that focus on biofilm prevention, wound healing, and pain therapy. The company is headquartered in Elmsford, New York."
CIK="1326706"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES"
Address="525 EXECUTIVE BOULEVARD, ELMSFORD, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="5452400"
EBITDA="-4696592"
PERatio="None"
PEGRatio="0"
BookValue="1.325"
DividendPerShare="0"
DividendYield="0"
EPS="-3.59"
RevenuePerShareTTM="0.562"
ProfitMargin="0"
OperatingMarginTTM="-5.63"
ReturnOnAssetsTTM="-0.471"
ReturnOnEquityTTM="-1.45"
RevenueTTM="834000"
GrossProfitTTM="167000"
DilutedEPSTTM="-3.59"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.301"
AnalystTargetPrice="10.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="6.44"
PriceToBookRatio="3.718"
EVToRevenue="6.0"
EVToEBITDA="-1.669"
Beta="0.852"
num_52WeekHigh="15.4"
num_52WeekLow="2.94"
num_50DayMovingAverage="3.607"
num_200DayMovingAverage="5.5"
SharesOutstanding="1662300"
DividendDate="None"
ExDividendDate="None"
symbol="NAOV"
open="3.36"
high="3.36"
low="3.23"
price="3.28"
volume="3868.00"
latest_trading_day="2023-07-07"
previous_close="3.35"
change="-0.07"
change_percent="-2.0866%"
aroon_positive_momentum_days="31"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="31"
Volume_recent_avg="15496"
Change_recent_avg="0.01"
Delta_recent_avg="0.26"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-0.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="31"
Aroon_momentum_negative="69"
image_negative_thumbnail_id_1="1110"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0143.jpeg"
image_negative_thumbnail_id_2="489"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0116.jpeg"
image_neutral_thumbnail_id_1="590"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_neutral_thumbnail_id_2="574"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_positive_thumbnail_id_1="702"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0006.jpeg"
image_positive_thumbnail_id_2="630"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0078.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
